The Cost Effectiveness of Apligraf?? Treatment of Diabetic Foot Ulcers
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (16) , 1171-1183
- https://doi.org/10.2165/00019053-200321160-00003
Abstract
Background:Diabetic foot ulcers (DFUs) present a treatment challenge and result in a large economic burden, requiring careful evaluation of the clinical efficacy and cost effectiveness of new...Keywords
This publication has 16 references indexed in Scilit:
- Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.PharmacoEconomics, 2001
- The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost DataValue in Health, 2000
- Healing of Diabetic Foot Ulcers and Pressure Ulcers With Human Skin EquivalentArchives of Surgery, 2000
- The burden of diabetic foot ulcersThe American Journal of Surgery, 1998
- The impact of diabetes-related lower-extremity amputations in the NetherlandsJournal of Diabetes and its Complications, 1996
- The Costs of Diabetes‐related Lower Extremity Amputations in the NetherlandsDiabetic Medicine, 1995
- Long-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary SettingFoot & Ankle International, 1995
- Diabetic foot ulcers in a multidisciplinary setting An economic analysis of primary healing and healing with amputationJournal of Internal Medicine, 1994
- The economic costs of non-insulin-dependent diabetes mellitusPublished by American Medical Association (AMA) ,1989
- The Dysvascular Foot: A System for Diagnosis and TreatmentFoot & Ankle, 1981